Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille(Antwerp University Hospital), Zwi Berneman(University of Antwerp), Ronald Malfait(Antwerp University Hospital), Haruo Sugiyama(The University of Osaka), Kathleen Deiteren(Antwerp University Hospital), Ann L. Van de Velde(University of Antwerp), Eva Lion(University of Antwerp), Irma Vandenbosch(Antwerp University Hospital), Katrien Vermeulen(University of Antwerp), Alain Gadisseur(Antwerp University Hospital), Griet Nijs(University of Antwerp), Fumihiro Fujiki(Osaka University of Economics), Gunnar Juliusson(Lund University), Marie‐Berthe Maes(Antwerp University Hospital), Marie M. Couttenye(University of Antwerp), Viggo Van Tendeloo(Infectious Diseases Institute), Yusuke Oji(The University of Osaka), Anke Verlinden(Antwerp University Hospital), Kristin Ladell(Cardiff University), Nathalie Cools(University of Antwerp), Wilfried Schroyens(Antwerp University Hospital), Emma Gostick(University Hospital of Wales), Philippe G. Jorens(University of Antwerp), Evelien Smits(University of Antwerp), L. Muylle(Antwerp University Hospital), Martin Lammens(Radboud University Nijmegen), David A. Price(University Hospital of Wales), Yoshitaka Oka(The University of Tokyo), Ann Van Driessche(University of Antwerp), Barbara Stein(University of Antwerp), Herman Goossens(University of Antwerp)
Blood
August 22, 2017
Cited by 235


Related Papers